EN Ireland

David Jin


David Jin

David Jin is a member of Barings Alternative Investments, a global real estate, private equity and real assets platform. David is a part of the Private Equity/Real Assets team and is responsible for sourcing and underwriting Pharmaceutical investments. David has worked in the industry since 2012. Prior to joining the firm in 2017, David was a Director of Corporate Development for Sorrento Therapeutics, a clinical-stage antibody-focused biopharma company, where he was involved with clinical/portfolio strategy and acquisitions. Prior to that, David was a management consultant at IQVIA, consulting for global pharmaceutical companies on market access, pricing, transaction advisory, and strategy and portfolio analysis. David received a B.S. from Northwestern University, where he graduated from the Mathematical Methods in the Social Sciences program with a double major in Industrial Engineering.


We use cookies on our website to provide you with the best experience. By proceeding to our site you agree to our Cookies Notice and our site Terms and Conditions.